Effects of uremic ultrafiltrate on the regulation of the parathyroid cell cycle by calcitriol.

BACKGROUND Calcitriol (CTR) is used in the treatment of hyperparathyroidism secondary to renal failure because it decreases parathyroid hormone (PTH) synthesis and parathyroid cell proliferation. Previous studies in tissues other than parathyroids have demonstrated that uremic factors affect the action of CTR on the target cells. We questioned whether the uremic milieu interferes with the inhibition of parathyroid cell proliferation by CTR. METHODS Studies were performed in vitro using freshly excised normal dog parathyroid tissue incubated for 24 hours with and without CTR and in the presence of either total uremic ultrafiltrate (UUF) from uremic patients or high-pressure liquid chromatography (HPLC)-derived fractions (hydrophilic compounds eluting early and hydrophobic compounds eluting late) of this UUF (F1 to F4). Parathyroid cell proliferation was assessed by flow cytometry. RESULTS The addition of CTR 10-8 and 10-7 mol/L to parathyroid tissue produced an inhibition of the proliferation that was prevented in the presence of UUF. In a medium containing CTR 10-8 mol/L, the addition of F1, F2 and F3, but not F4, prevented the CTR-induced inhibition of parathyroid cell proliferation. With CTR 10-7 mol/L, the inhibition of proliferation was observed even in the presence of F1, F2 and also F4, but was prevented by F3. Uric acid (7 mg/dL), indoxyl sulfate (5 mg/dL) and p-cresol (1.4 mg/dL), which coeluted with F1, F2 and F4, respectively, did not interfere with the inhibitory action of CTR 10-7 mol/L; however, the addition of phenol (0.14 mg/dL), which coeluted with F3, prevented the CTR-induced inhibition of parathyroid cell proliferation. CONCLUSIONS The presence of uremic toxins prevents the inhibition of parathyroid cell proliferation induced by calcitriol.

[1]  H. Schlüter,et al.  Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure. , 2001, Kidney international. Supplement.

[2]  J. Farndon,et al.  Changes in cytoplasmic calcium determine the secretory response to extracellular cations in human parathyroid cells: a confocal microscopy study using FM1-43 dye. , 2000, The Biochemical journal.

[3]  V. Torregrosa,et al.  The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis. , 2000, Journal of the American Society of Nephrology : JASN.

[4]  T. Drüeke,et al.  Cell biology of parathyroid gland hyperplasia in chronic renal failure. , 2000, Journal of the American Society of Nephrology : JASN.

[5]  C. Carlberg,et al.  Inhibitory effect of uremic solutions on protein‐DNA‐complex formation of the vitamin D receptor and other members of the nuclear receptor superfamily , 1999, Journal of cellular biochemistry.

[6]  R. Vanholder,et al.  Uremic Ultrafiltrate Inhibits Platelet-Activating Factor Synthesis , 1999, Blood Purification.

[7]  R. Vanholder,et al.  Inhibition of calcitriol-induced monocyte CD14 expression by uremic toxins: role of purines. , 1998, Journal of the American Society of Nephrology : JASN.

[8]  J. Gogusev,et al.  Persistence of Ca2+‐Sensing Receptor Expression in Functionally Active, Long‐Term Human Parathyroid Cell Cultures , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  C. Hsu,et al.  Uremic toxins and vitamin D metabolism. , 1997, Kidney international. Supplement.

[10]  R. Vanholder,et al.  Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. , 1995, The Journal of clinical investigation.

[11]  Sanjeevkumar R. Patel,et al.  Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: calcitriol receptor interaction with its target gene in renal failure , 1995, Current opinion in nephrology and hypertension.

[12]  R Vanholder,et al.  Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate. , 1994, Kidney international.

[13]  K. Kurokawa,et al.  Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. , 1993, The Journal of clinical investigation.

[14]  R. Vanholder,et al.  Mechanism of decreased intestinal calcitriol receptor concentration in renal failure. , 1993, The American journal of physiology.

[15]  C. Hsu,et al.  Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity. , 1992, Journal of the American Society of Nephrology : JASN.

[16]  G. Hendy,et al.  Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. , 1989, Endocrinology.

[17]  R. Vanholder,et al.  Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  Y. Koga,et al.  Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. , 1996, Nephron.

[19]  I. Christensen,et al.  Detergent and proteolytic enzyme-based techniques for nuclear isolation and DNA content analysis. , 1994, Methods in cell biology.

[20]  H. Koyama,et al.  Effect of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of human promyelocytic leukemia cell, HL-60. , 1993, Nephron.

[21]  Sanjeevkumar R. Patel,et al.  Uremic Plasma Contains Factors Inhibiting la-Hydroxylase I , 1992 .